Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Conditions

• Ultomiris-exposed Pregnant/ Postpartum
• Pregnancy
• Paroxysmal Nocturnal Hemoglobinuria (PNH)
• Atypical Hemolytic Uremic Syndrome (aHUS)
• Generalized Myasthenia Gravis (gMG)
• Neuromyelitis Optica Spectrum Disorder (NMOSD)

Interventions

• DRUG: Ultomiris

Sponsor

Alexion Pharmaceuticals, Inc.